ETFs positioned on Abbott Laboratories

Name YTD change Weight AuM
0.00% - 1 M€
+2.95% - 165 M€
+9.73% - 67 M€
+16.80% - 35,761 M€
+11.87% - 122 M€
+4.18% - 49 M€
+9.91% - 143 M€
+2.00% - 293 M€
+4.24% - 37 M€
+11.38% - 28 M€
+12.12% - 1,674 M€
+9.40% - 27,154 M€
+11.78% - 66 M€
-12.16%18.52% 3,478 M€
-13.18%17.54% 234 M€
+7.85%7.18% 61 M€
0.00%4.99% 5 M€
0.00%4.99% 4 M€
+10.35%4.99% 86 M€
+24.87%4.93% 513 M€
+20.58%4.77% 3,009 M€
+7.25%4.75% 33 M€
+34.32%4.32% 11 M€
+17.46%4.31% 941 M€
+22.98%4.19% 12 M€
+18.15%4% 28 M€
+20.55%3.89% 563 M€
+17.85%3.88% 140 M€
0.00%3.88% 9 M€
+19.43%3.77% 43,868 M€
+10.16%3.77% 56 M€
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. ETFs Abbott Laboratories